INTRATUSS Susp
MRP: 148
Packaging: 100ML
Pack Type: suspension
Composition:
Levocloperastine Fendizoate 35.4 mg + Levocloperastine Hydrochloride 20 mg
Indication:
For short term treatment of dry cough. It is also used to treat chronic cough or coughs caused due to smoking, emphysema and asthma.
Description:
This combination is a centrally acting cough suppressant with strong antitussive and mild antihistaminic activity. Levocloperastine works by inhibiting the cough reflex at the medullary level and providing relief from persistent dry or allergic cough without causing sedation or addiction.
Composition Breakdown
Levocloperastine Fendizoate 35.4 mg – a prodrug form with extended effect.
Levocloperastine Hydrochloride 20 mg – active form that acts directly on the cough center.
This formulation is beneficial for dry, spasmodic, allergic, or post-infectious coughs, especially in sensitive individuals.
Tags:
- Relieves persistent dry or allergic cough
- Non-narcotic, non-sedative, and non-habit forming
- Provides long-lasting relief
- Suitable for children and elderly
- Useful in post-viral and nocturnal cough
Usage Information
Dosage
Adults: Tablet: 20 mg once or twice daily Syrup: 10 ml twice daily Children (2–12 years): Syrup: 5 ml twice daily (under physician guidance) Do not exceed the recommended dose. Shake syrup well before use.
Side Effects
Mild dizziness Headache Gastrointestinal upset (nausea or abdominal discomfort) Skin rash (rare) Generally well tolerated. Does not cause drowsiness like traditional antihistamines or codeine.
Contraindications
Known hypersensitivity to Levocloperastine Severe liver or kidney impairment Use with caution in pregnant or lactating women Not recommended for children under 2 years
Availability
levocloperastine cough syrup • non-sedative dry cough medicine • dry cough suppressant • antitussive for allergic cough • best medicine for irritating cough